|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.94 USD | +3.18% |
|
+6.29% | -19.47% |
| Apr. 18 | Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing | MT |
| Apr. 16 | Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer | MT |
The
The biotechnology company posted revenue of
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from
Copyright by Automated Insights, Inc. All rights reserved., source
| 1st Jan change | Capi. | |
|---|---|---|
| -19.47% | 1.89B | |
| -1.51% | 104B | |
| +3.22% | 97.42B | |
| +1.51% | 22.2B | |
| -16.53% | 21.23B | |
| -8.77% | 18.33B | |
| -42.33% | 16.35B | |
| -20.09% | 15.06B | |
| +5.47% | 13.98B | |
| +28.85% | 11.66B |
RECURSION PHARMACEUTICALS, INC. 
